White Blood Cell Count Determination in Mastitis Mouse Models: Technical Overview, Methods, and Appl

White blood cell (WBC) count determination in mastitis mouse models is a core hematological assay for quantifying the inflammatory response in experimentally induced mammary gland infections. This technical guide explains the sample types, testing parameters, analytical methods, and research applications of leukocyte counting in murine mastitis studies. Accredited third-party laboratories apply validated protocols and standardized animal husbandry practices to deliver accurate, reproducible data for preclinical research.

Technical Overview

Mastitis is an inflammatory disease of the mammary gland that can be experimentally reproduced in mice through intraductal or intramammary inoculation of pathogens such as Staphylococcus aureus, Escherichia coli, or Streptococcus agalactiae. The murine model is widely used in preclinical research because it faithfully recapitulates the key features of clinical mastitis, including massive leukocyte infiltration, elevated pro-inflammatory cytokines, alveolar tissue damage, and bacterial burden in the gland.

White blood cell counting serves as a quantitative biomarker of both systemic and local inflammation. During acute mastitis, circulating neutrophils rise sharply (neutrophilia), and large numbers of leukocytes migrate from the peripheral blood into the mammary parenchyma and ductal secretions. Serial measurement of total and differential leukocyte counts allows researchers to achieve the following:

• Stage the severity and progression of mammary gland inflammation
• Compare the virulence and inflammatory potential of different bacterial strains
• Evaluate the efficacy of antimicrobial and anti-inflammatory therapies
• Assess the immunomodulatory effects of candidate compounds and biologics

Testing Samples

Peripheral Blood

Whole blood is collected from the tail vein, submandibular vein, retro-orbital sinus, or by cardiac puncture under anesthesia. Samples are anticoagulated with dipotassium or tripotassium EDTA and analyzed promptly to preserve cell morphology and counting accuracy.

Mammary Gland Tissue Homogenates

The inguinal (fourth) or abdominal mammary glands are excised at necropsy, weighed, and homogenized in sterile phosphate-buffered saline. The homogenate is used for leukocyte counting, myeloperoxidase (MPO) activity measurement, and serial dilution plating to determine bacterial colony-forming units (CFU), providing a direct index of local inflammatory cell infiltration.

Mammary Lavage Fluid and Whey

Ductal lavage fluid or whey recovered from the gland reflects the local immune response. Somatic cell counts and differential leukocyte profiles in these fluids correlate closely with the severity of intramammary infection.

Bone Marrow (Optional)

Femoral bone marrow aspirates may be collected in mechanistic studies to evaluate the granulopoietic response and bone marrow neutrophil reserve mobilization during acute infection.

Testing Items

Testing panels for mastitis mouse models are typically structured as follows:

• Total white blood cell count (WBC) in peripheral blood and gland homogenates
• Differential leukocyte count: neutrophils, lymphocytes, monocytes, eosinophils, and basophils
• Neutrophil-to-lymphocyte ratio (NLR) as an index of systemic inflammatory stress
• Somatic cell count (SCC) in whey or lavage fluid
• Myeloperoxidase (MPO) activity in mammary tissue homogenates
• Correlative endpoints: bacterial CFU load, cytokine levels (TNF-α, IL-1β, IL-6, IL-10), and histopathological scoring of H&E-stained sections

Testing Methods

Manual Hemocytometer Counting

Blood or tissue homogenate is diluted in a Türk-type acetic acid lysing solution that eliminates red blood cells while preserving leukocyte nuclei. Cells are counted in a Neubauer-improved counting chamber under light microscopy according to internationally recognized reference procedures for manual cell enumeration. This method remains the benchmark against which automated systems are validated.

Automated Hematology Analysis

Impedance-based or laser flow-cytometric hematology analyzers configured with murine species settings deliver total WBC, five-part differential, red cell, and platelet parameters with high throughput and low inter-operator variability. Calibration and daily quality controls with two-level control materials ensure result traceability.

Wright-Giemsa Stained Smears

Blood or homogenate smears are stained with Wright-Giemsa stain, and manual 100- to 200-cell differential counts are performed to verify analyzer results, identify band neutrophils (left shift), and detect toxic granulation or other morphologic changes characteristic of bacterial infection.

Flow Cytometric Immunophenotyping

Single-cell suspensions from blood, gland digests, or bone marrow are stained with fluorochrome-conjugated antibodies against CD45 (pan-leukocyte), Ly6G (neutrophils), CD11b (myeloid cells), and F4/80 (macrophages) to quantify infiltrating leukocyte subsets with high specificity.

Myeloperoxidase Activity Assay

A colorimetric or fluorometric enzymatic assay on gland homogenates provides an indirect, quantitative measure of neutrophil accumulation in tissue, complementing direct cell counting.

All animal procedures are conducted under institutional animal care and use committee (IACUC) approval, with housing and husbandry compliant with GB 14925 governing laboratory animal environments and facilities. Hematological procedures follow internally validated standard operating procedures aligned with internationally recognized reference methods.

Applications

White blood cell count determination in mastitis mouse models supports a broad range of preclinical and academic applications:

• Efficacy screening of antibiotics, anti-inflammatory agents, and natural product extracts against experimental mastitis
• Pathogenesis research on S. aureus, E. coli, and other intramammary pathogens
• Evaluation of mastitis vaccines and passive immunotherapies
• Immunomodulation studies of probiotics, nutraceuticals, and bioactive compounds
• Biomarker discovery and mechanistic studies of leukocyte recruitment and resolution of inflammation
• Preclinical data packages supporting regulatory submissions and peer-reviewed publication

FAQ

When should WBC counts be measured after mastitis induction?

In acute models, circulating WBC and neutrophil counts typically begin to rise within 12 to 24 hours after intramammary challenge, often peaking at 24 to 48 hours. Recommended sampling time points should be tailored to the pathogen, inoculum dose, and study objectives, and are usually established through pilot kinetic studies.

How much blood is required for the assay?

Approximately 20 to 50 µL of whole blood is sufficient for total and differential counts on modern analyzers or by manual methods. When multiple hematological and biochemical assays are combined, terminal collection of 0.5 to 1 mL by cardiac puncture under deep anesthesia may be performed.

Why does the neutrophil proportion increase during mastitis?

Bacterial products such as lipoteichoic acid and lipopolysaccharide trigger the release of neutrophils from bone marrow reserves and their active recruitment to the infected gland via chemokine signaling. The resulting neutrophilia, accompanied by a left shift, is a hematological hallmark of acute bacterial mastitis.

How are WBC results interpreted alongside other endpoints?

Leukocyte data gain the most value when interpreted together with mammary bacterial CFU counts, cytokine profiles measured by ELISA or qPCR, MPO activity, and histopathological scoring of gland sections. A combined analysis distinguishes effective antimicrobial and anti-inflammatory interventions from partially effective or ineffective treatments.

What quality measures ensure reliable results?

Reliability is ensured through analyzer calibration and daily quality control, replicate manual counts with acceptance criteria for chamber agreement, randomized and blinded sample processing, appropriate negative and infection controls, and consistent sampling times across experimental groups to minimize biological variability.